Anavex Life Sciences Corp (AVXL)

[falconer66a]

Alzheimer’s Walks Next Year

This, and other similar public “walks” and demonstrations, prompted by an expanded, dare I say even desperate, search for a solution to the Alzheimer’s Problem, should not go unnoticed. We baby boomers are aging out, with millions of us facing the prospects of geriatric dementias, the most prominent of which is Alzheimer’s disease.

The stark reality of there being no useful, effective treatment or prevention of Alzheimer’s confronts modern society. Formerly, the affliction was reasonably rare; could be neglected. But, today, probably a majority of families have distant members suffering as either Alzheimer’s care givers or patients. Everyone with such arrangements has asked, “What can be done for Aunt Sally?” Nothing. She will suffer, then die.

The futility of treating or caring for an Alzheimer's patient (or relative) is evermore frustrated by the now-recognized failures of both Aricept and Aduhelm. Aricept, for a short or moderate period, only slows the lethal progression of the disease. Aduhelm is unbelievably expensive (health insurance may not pay for it), and it has very bad side effects, and yields very moderate symptomatic relief, which does not endure.

Simply, there are no treatment or prevention modalities for this horrible disease.

What, then, might happen when, next year, Anavex announces the very favorable results of their big Phase 3 Alzheimer’s clinical study? Will those people participating in Alzheimer’s marches merely blink their eyes and walk on? Or, will they take their concerns to both legislators and federal health agency officials? How soon would there be new Alzheimer’s marches, with signs and shouts: “We Want Blarcamesine!?”

When they appear, blarcamesine’s Alzheimer’s clinical data will change everything.